Company Profile of Ningxia Qiyuan Pharmaceutical Co., Ltd.

The company integrates R&D, production and sales, and has the production capacity of raw materials and various Chinese and Western medicine preparations. The raw materials erythromycin series, tetracycline hydrochloride series, avermectin series, and vitamin series are leading the way. Its advanced technology, excellent quality, large-scale production and strong development momentum have made it famous at home and abroad. Its leading products, erythromycin and tetracycline hydrochloride series of APIs, rank first in the world in terms of scale, with sales markets all over the world.

The subsidiary Ningxia Qiyuan Sinopharm Co., Ltd. can produce more than 300 varieties and specifications of Chinese and Western medicine preparations such as tablets, injections, capsules, granules, pills, and suppositories. Featured preparations include Jinlian Qingre Granules, Wolfberry Yishen Capsules, Jinjingkang, Matrine Suppository, Qirong Tablets, Matrine Injection, Shanzhajing Lipid-Reducing Tablets, Fuxin Tablets, Qisheng Capsules, Liuwei Dihuang Pills (concentrated pills ), Xiaoshi Jianwei tablets, etc. Among them, Jinlian Qingre Granules are a national exclusive variety. The subsidiary Ningxia Qiyuan Pharmacy Pharmaceutical Co., Ltd. has a number of chain pharmacies throughout the region, which are deeply favored by the people.

The company adheres to the corporate philosophy of "integrity-based, efficiency first" and the purpose of "building a world-famous and healthy China". It always regards the safe and effective use of medicines by the people as its mission. By virtue of its consistent The product quality has enabled the company to be widely recognized by the market, and it has been awarded the title of "contract-abiding and credit-worthy enterprise" at the district and municipal levels for many years in a row. The company has been rated as a national key high-tech enterprise and one of the top 100 key export enterprises in the country for promoting trade through science and technology. National enterprise technology center, national postdoctoral workstation. Tetracycline hydrochloride API has passed US FDA certification, European COS certification and EU EUGMP certification. All production workshops have passed national GMP certification.

In the new historical period, Qiyuan Pharmaceutical takes the scientific outlook on development as its guidance, uses advanced scientific research, technology, and management to give full play to Ningxia's regional advantages, and takes the big market as the background and plans from a high starting point to make Ningxia Pharmaceutical oriented to China and oriented. A strong product and advantageous enterprise in the world's pharmaceutical market. Since 2003, the company has continuously invested more than 1 billion yuan to complete the technical transformation project of erythromycin series products and other supporting projects, making Qiyuan Pharmaceutical's fermentation scale among the best in the country. , one of the top 100 pharmaceutical companies in China.

In the process of development, the company adheres to clean production and source control, always regards environmental protection as a "life project", and constantly adopts advanced environmental protection technologies. In the past few years, the company has invested more than 200 million yuan in the construction of environmental protection facilities. Environmental protection projects have taken the lead in all projects, achieving a win-win situation for both economic and environmental benefits.

Qiyuan Pharmaceutical. We sincerely invite people of insight from all walks of life at home and abroad who are committed to the development of China's pharmaceutical industry to join us through investment, sales and technical cooperation. We cherish every cooperation opportunity!